Evidence map›Paper›PMID 29969250›Full record

ArticleBiochemistry2018

Stereospecific Radical-Mediated B

Martin I McLaughlin, Wilfred A van der Donk

Abstract read
In one paragraph

Article in Biochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Late-Stage Posttranslational Assembly of Fosfazinomycins.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biosynthesis of 3-thia-α-amino acids on a carrier peptide.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  7. Cobalamin-Dependent RadicalACS bio & med chem Au · 2022
    Review
  8. The Atypical Cobalamin-DependentJournal of the American Chemical Society · 2022
    Article
  9. Article
  10. Studies of GenK and OxsB, two BMethods in enzymology · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Martin I McLaughlin
Wilfred A van der DonkORCID 0000-0002-5467-7071
Howard Hughes Medical Institute · USUniversity of Illinois Urbana-Champaign · US

Funding

Structural Elucidation and Biosynthesis P01GM077596 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI EVANS, BRADLEY S. · 2007 to 2016
$15.3M
Request for a Varian 600 MHz NMR InstrumentS10RR028833 · NCRR · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI VAN DER DONK, WILFRED A. · 2011 to 2011
$600k
NCRR NIH HHS S10 RR028833NIGMS NIH HHS P01 GM077596
6 · The paper itself

Abstract

Fom3, the antepenultimate enzyme in the fosfomycin biosynthetic pathway in Streptomyces spp., is a class B cobalamin-dependent radical SAM methyltransferase that catalyzes methylation of (5'-cytidylyl)-2-hydroxyethylphosphonate (2-HEP-CMP) to form (5'-cytidylyl)-2-hydroxypropylphosphonate (2-HPP-CMP). Previously, the reaction of Fom3 with 2-HEP-CMP produced 2-HPP-CMP with mixed stereochemistry at C2. Mechanistic characterization has been challenging because of insoluble expression and poor cobalamin (B

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCytidine MonophosphateEscherichia coliFosfomycinFree RadicalsMethylationMethyltransferasesModels, ChemicalOrganophosphonatesS-AdenosylmethionineStereoisomerismStreptomycesVitamin B 12Anti-Bacterial AgentsBacterial ProteinsCytidine MonophosphateFosfomycinFree RadicalsMethyltransferasesOrganophosphonatesS-AdenosylmethionineVitamin B 12

Identifiers

PMID29969250
PMCPMC6103835
OpenAlexW2810159838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.